- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03683472
Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder
May 14, 2020 updated by: Judson Brewer, MindSciences, Inc.
The investigators propose to develop and adapt Unwinding Anxiety phone app specifically for individuals with generalized anxiety disorder.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study aims are to (1) develop and refine Unwinding Anxiety for individuals with generalized anxiety disorder, (2) determine user engagement and acceptability as well as measure effect sizes of the program vs. treatment as usual, and (3) preliminarily test mechanisms of action.
The knowledge gained will set the stage for a number of future studies related to further elucidating the mechanisms of mindfulness, and the clinical efficacy and utility of this type of training delivered via digital therapeutics in general.
Specifically, this study will provide necessary variances for powering larger phase 2 studies.
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02912
- Brown University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Owns a smart phone
- GAD - 7 is equal to or greater than 10
Exclusion Criteria:
- If using psychotropic medication - not on a stable dosage for at least 6 weeks
- Medical disorder of the severity that would interfere with ability to participate
- Not being fluent in English (due to instructions provided in English)
- As needed use (i.e. prn) of benzodiazepines
- Psychotic disorder,
- Previous MT (e.g. MBSR, other Claritas MindSciences training programs).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Treatment as usual (TAU)
Individuals will receive treatment as usual
|
|
Active Comparator: TAU and Unwinding Anxiety Phone App
The Unwinding Anxiety program focuses on teaching individuals 1) to understand how anxious worry is developed and perpetuated through reinforcement learning, 2) how to recognize these worry "habit loops" and 3) how to bring mindful awareness to moments of worry such that they can uncouple feelings of anxiety from reactive worry thinking and "ride out" habitual mind states that perpetuate and reinforce anxiety.
Together, these help individuals "unlearn"/extinguish worry at a core mechanistic level.
|
The Unwinding Anxiety program focuses on teaching individuals 1) to understand how anxious worry is developed and perpetuated through reinforcement learning, 2) how to recognize these worry "habit loops" and 3) how to bring mindful awareness to moments of worry such that they can uncouple feelings of anxiety from reactive worry thinking and "ride out" habitual mind states that perpetuate and reinforce anxiety
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
UA Program engagement
Time Frame: Two months
|
Number of modules completed
|
Two months
|
Change in worry
Time Frame: Baseline, two months
|
Penn State Worry Questionnaire (PSWQ)
|
Baseline, two months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in non-reactivity & awareness
Time Frame: Baseline, two months
|
Five Facet Mindfulness Questionnaire - Non-Reactivity subscale (FFMQ)
|
Baseline, two months
|
UA Program Acceptability
Time Frame: Two months
|
Net Promoter Score (NPS)
|
Two months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in anxiety
Time Frame: Baseline, two months
|
Generalized Anxiety Disorder - 7 items (GAD-7)
|
Baseline, two months
|
Change in self-regulation
Time Frame: Baseline, two months
|
Multidimensional Assessment of Interoceptive Awareness (MAIA)
|
Baseline, two months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Judson Brewer, Brown University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 20, 2019
Primary Completion (Actual)
October 17, 2019
Study Completion (Actual)
October 17, 2019
Study Registration Dates
First Submitted
June 11, 2018
First Submitted That Met QC Criteria
September 21, 2018
First Posted (Actual)
September 25, 2018
Study Record Updates
Last Update Posted (Actual)
May 18, 2020
Last Update Submitted That Met QC Criteria
May 14, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R41MH118130-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Disorders
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
Clinical Trials on Unwinding Anxiety Phone App
-
Yeshiva UniversityNot yet recruiting
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
University of Notre DameUniversity of RochesterRecruitingSuicidal Ideation | Self HarmUnited States
-
Northwestern UniversityCompletedDepression | AnxietyUnited States
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV | Pre-exposure ProphylaxisChina
-
Unity Health TorontoUnknownSleep | PregnancyCanada
-
Maltepe UniversityCompletedInfertility | Infertility, FemaleTurkey
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)Completed
-
University of MichiganWashington University School of Medicine; National Institute of Nursing Research...Completed
-
Kaohsiung Medical University Chung-Ho Memorial...Completed